Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 613-915-0 | CAS number: 66233-43-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 973
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- For dose level determination in main study preliminary study was conducted with following doses: 5, 10, 20, 35 and 50 mg/kg with 7-10 animals (rats or mice) /group. Pregnant animals reveived test substance from gestation day 7 to 13. Termination by caesarean section on day 21 (rat) or 18 (mouse).
Teratogenicity study: 15 dams/group were exposed to fluocortolone (5 or 10 mg/kg for rats; 5 or 20 mg/kg for mice) on gestation day 7 to 13. Termination by caesarean section on day 21 (rat) or 18 (mouse).
Postnatal study: 5 dams/group were exposed to fluocortolone (5 or 10 mg/kg for rats; 5 or 20 mg/kg for mice) on gestation day 7 to 13. Dams remained for spontanous delivery. Termination of study on day 21 post partum. - GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- Fluocortolone
- EC Number:
- 205-811-5
- EC Name:
- Fluocortolone
- Cas Number:
- 152-97-6
- Molecular formula:
- C22H29FO4
- IUPAC Name:
- 6-fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
- Details on test material:
- - Name of test material (as cited in study report): Fluocortolone (ZK 10445)
Constituent 1
Test animals
- Species:
- other: rats and mice
- Strain:
- other: Rat: SD-JCL strain; Mouse: ICR-JCl strain
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Nippon-Clare, Osaka
- Age at study initiation: rats: 10-13 weeks, mice 8-10 weeks
- Housing: cohoused over night
- Diet (e.g. ad libitum): ad libitum, solid food CA-1 supplied by.Nippon-Clare
- Water (e.g. ad libitum): ad libitum
- Acclimation period: not reported
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 1
- Humidity (%): 50-60
Administration / exposure
- Route of administration:
- subcutaneous
- Vehicle:
- castor oil
- Analytical verification of doses or concentrations:
- no
- Details on mating procedure:
- - Impregnation procedure: cohoused
- If cohoused:
- M/F ratio per cage: over night
- Length of cohabitation: no data
- Proof of pregnancy: vaginal plug or sperm in vaginal smear referred to as day 0 of pregnancy
- Any other deviations from standard protocol: no - Duration of treatment / exposure:
- 7 days (on gestation days 7 to 13)
- Frequency of treatment:
- once daily
- Duration of test:
- 15 rats/group until day 21 of pregnancy. Termination by caesarean section.
5 dams remained for spontanous delivery. Termination of study on day 21 post partum
15 mice/group until day 18 of pregnancy. Termination by caesarean section.
5 dams remained for spontanous delivery. Termination of study on day 21 post partum
Doses / concentrationsopen allclose all
- Dose / conc.:
- 20 mg/kg bw/day
- Remarks:
- mice high dose, main experiment
- Dose / conc.:
- 10 mg/kg bw/day
- Remarks:
- high dose rats, main experiment
- Dose / conc.:
- 5 mg/kg bw/day
- Remarks:
- mice and rats, low dose, main experiment
- Dose / conc.:
- 50 mg/kg bw/day
- Remarks:
- preliminary study
- Dose / conc.:
- 35 mg/kg bw/day
- Remarks:
- preliminary study
- Dose / conc.:
- 20 mg/kg bw/day
- Remarks:
- preliminary study
- Dose / conc.:
- 10 mg/kg bw/day
- Remarks:
- preliminary study
- Dose / conc.:
- 5 mg/kg bw/day
- Remarks:
- preliminary study
- No. of animals per sex per dose:
- 20 pregnant females/dose
- Control animals:
- yes, concurrent vehicle
Results and discussion
Results: maternal animals
Effect levels (maternal animals)
open allclose all
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- mouse
- Effect level:
- >= 5 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- other: maternal toxicity
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- rat
- Effect level:
- >= 10 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- other: maternal toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:yes. Remark: cleft palate in mice
Effect levels (fetuses)
open allclose all
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- mouse
- Effect level:
- >= 5 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- other: embryotoxicity
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- rat
- Effect level:
- >= 5 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- other: embryotoxicity
- Key result
- Dose descriptor:
- LOAEL
- Remarks:
- mouse
- Effect level:
- >= 5 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- other: teratogenicity
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
Preliminary dose selection study: Rats: at >20 mg/kg almost all rat fetuses and at 10 mg/kg ca. half fetuses were resorbed or dead. The number of death in dams were 8/10 at 50 mg/kg, 10/10 at 35 mg/kg, 7/10 at 20 mg/kg and 1/8 in 10 mg/kg.
Mice: at >35 mg/kg almost all fetuses and at 20 mg/kg ca. half fetuses were resorbed or dead. In high dose group (50 mg/kg) 1/10 mouse died.
Teratogenicity study: Reduced body weight gain in mouse dams. Increase in embryomortality in mice and rats. Dose dependent occurrence of cleft palate in mice.
Post natal study: no substance-related effects observed.
Applicant's summary and conclusion
- Conclusions:
- Teratogenic effects in mice were observed.
Rats and mice (20 female/group) were treated subcutanously with fluocortolone at dose levels of 0, 5 or 10 mg/kg for (rats) and 0, 5 or 20 mg/kg (mouse) once daily on gestation days 7 -13. 15 dams per species were sacrificed via ceasarean section on day 18 (mouse) or 21 (rat) of pregnancy. 5 dams per species were kept for spontanous delivery. Study was terminated on day 21 post partum. Maternal toxicity was seen as a treatment-related reduction of body weight gain in mice at 20 mg/kg bw. The NOAEL for maternal toxicity was 5 mg/kg bw. Embryo lethal effects could be observed in mice and rats at high dose (NOAEL: 5 mg/kg for rats ans mice). No treatment-related teratogenic effects occurred in rats, but dose dependence occurrence of cleft palate was observed in mice. Substance related effects in offsprings did not occur. - Executive summary:
In a developmental/teratogenicity study conducted prior to implementation of OECD guidelines Fluocortolone (100 % a.i.) was administered subcutaneously to 20 female SD-JCL rats or ICR-JCL mice/dose in castor oil at dose levels of 0, 5 and 10 or 5 and 20 mg/kg bw/day, respectively, from days 7 through 13 of gestation.
In the preliminary study in rats at the dose of 20 mg/kg bw and 10 mg/kg bw respectively almost all rat fetuses were resorbed or dead and half of the rat fetuses were resorbed or dead. The number of dead animals in dams were 8/10 at 50 mg/kg, 10/10 at 35 mg/kg, 7/10 at 20 mg/kg and 1/8 in 10 mg/kg. In mice almost all fetuses were resorbed or dead at 35 mg/kg bw and at 20 mg/kg bw approximately half of the fetuses were resorbed or dead. In the high dose group (50 mg/kg bw) one mouse died.
In the main study a reduced body weight was determined in mouse dams at 20 mg/kg bw. Embryo lethality was observed in the high dose groups in both rats and mice. Cleft palate was observed in both high dose groups in rats and mice although there was only one case in rats and 4 cases in mice. However, cleft palate was also detected in the low dose group in mice (2 cases) and in the high dose group one case of the higher dosage group showed costal fusion and 1 of the lover dosage group sternal fusion as the symptom of skeletal malformation. The maternal NOAEL is > 10 mg/kg bw/day in rats and > 5 mg/kg bw in mice.
The growth in offspring of rats was not affected by the drug. No abnormalties were found. Both the treated groups and the control presented no external, thoracic and abdominal and skeletal malformations. Similar findings were made for the mice offspring. The drug exhibited no effecton the growth of offsprings. At the 21st day after birth, the skin, the auditory system and the behaviour in general were all normal. No external, thoracic and abdominal, and skeletal malformations were observed in both the treated groups and the control. The developmental LOAEL is > 5mg/kg bw/day in mice , based on on the increased incidence of cleft palate. The developmental NOAEL is > 5 mg/kg bw/day in both species based on the embryotoxicity that increased also fetal mortality in the high dose groups.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.